Endocrinology, Vol 131, 669-676, Copyright © 1992 by Endocrine Society

ARTICLES

Insulin regulation of messenger ribonucleic acid for the surfactant- associated proteins in human fetal lung in vitro

SA Dekowski and JM Snyder
Department of Pediatrics, University of Iowa College of Medicine, Iowa City 52242.

Respiratory distress syndrome (RDS) is primarily caused by an immaturity in the synthesis and secretion of surfactant by the fetal lung type II cell. Fetal hyperinsulinemia associated with maternal diabetes places the newborn at an increased risk of developing RDS, and therefore, it has been hypothesized that insulin inhibits type II cell differentiation. We have previously shown that insulin inhibits the accumulation of surfactant-associated protein A (SP-A), the major surfactant-associated protein, in human fetal lung explants maintained in vitro. In the present study, we used Northern blot analysis to evaluate the effects of insulin on the content of SP-A messenger RNA (mRNA) as well as on the content of mRNA for the hydrophobic surfactant- associated proteins SP-B and SP-C in human fetal lung explants maintained in vitro. Lung explants were maintained in serum-free medium with or without added insulin (0.25-2500 ng/ml) for up to 6 days. We observed that insulin, at concentrations of 25-2500 ng/ml, significantly inhibited the accumulation of SP-A mRNA when compared to controls (P less than 0.01). The inhibitory effect of insulin on SP-A mRNA accumulation was dose dependent with an approximately 75% inhibition observed at 2500 ng/ml. Insulin, at the concentration of 2500 ng/ml, significantly inhibited the accumulation of SP-B mRNA by approximately 30% when compared to control levels (P less than 0.01) but had no effect at lower concentrations. Insulin had no significant effect on SP-C mRNA levels at any concentration tested. Our findings provide evidence that insulin may delay fetal lung development by inhibiting SP-A and SP-B gene expression. A deficiency of these proteins in pulmonary surfactant may account for the increased incidence of RDS in infants of diabetic mothers.

This article has been cited by other articles:

				J. M. Fernandez-Real, B. Chico, M. Shiratori, Y. Nara, H. Takahashi, and W. Ricart Circulating Surfactant Protein A (SP-A), a Marker of Lung Injury, Is Associated With Insulin Resistance Diabetes Care, May 1, 2008; 31(5): 958 - 963. [Abstract] [Full Text] [PDF]

				D. Silva, M. Venihaki, W.-H. Guo, and M. F. Lopez Igf2 Deficiency Results in Delayed Lung Development at the End of Gestation Endocrinology, December 1, 2006; 147(12): 5584 - 5591. [Abstract] [Full Text] [PDF]

				B. Grubor, D. K. Meyerholz, and M. R. Ackermann Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet. Pathol., September 1, 2006; 43(5): 595 - 612. [Abstract] [Full Text] [PDF]

				O. L. Miakotina and J. M. Snyder Signal transduction events involved in TPA downregulation of SP-A gene expression Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1210 - L1219. [Abstract] [Full Text] [PDF]

				C. L. S. George, M. L. White, M. E. O'Neill, P. S. Thorne, D. A. Schwartz, and J. M. Snyder Altered surfactant protein A gene expression and protein metabolism associated with repeat exposure to inhaled endotoxin Am J Physiol Lung Cell Mol Physiol, December 1, 2003; 285(6): L1337 - L1344. [Abstract] [Full Text] [PDF]

				G. Wang, X. Guo, and J. Floros Human SP-A 3'-UTR variants mediate differential gene expression in basal levels and in response to dexamethasone Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L738 - L748. [Abstract] [Full Text] [PDF]

				J. M. Klein, T. A. McCarthy, J. M. Dagle, and J. M. Snyder Pre- and Postnatal Lung Development, Maturation, and Plasticity: Antisense inhibition of surfactant protein A decreases tubular myelin formation in human fetal lung in vitro Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L386 - L393. [Abstract] [Full Text] [PDF]

				J. M. Klein, T. A. McCarthy, J. M. Dagle, and J. M. Snyder Antisense Inhibition of Epidermal Growth Factor Receptor Decreases Expression of Human Surfactant Protein A Am. J. Respir. Cell Mol. Biol., June 1, 2000; 22(6): 676 - 684. [Abstract] [Full Text]

				N. V. Patel, M. J. Acarregui, J. M. Snyder, J. M. Klein, M. X. Sliwkowski, and J. A. Kern Neuregulin-1 and Human Epidermal Growth Factor Receptors 2 and 3 Play a Role in Human Lung Development In Vitro Am. J. Respir. Cell Mol. Biol., April 1, 2000; 22(4): 432 - 440. [Abstract] [Full Text]

				K. L. Goss, A. R. Kumar, and J. M. Snyder SP-A2 Gene Expression in Human Fetal Lung Airways Am. J. Respir. Cell Mol. Biol., October 1, 1998; 19(4): 613 - 621. [Abstract] [Full Text]

				J. M. Klein, L. J. Dewild, and T. A. McCarthy Effect of tyrosine kinase inhibition on surfactant protein A gene expression during human lung development Am J Physiol Lung Cell Mol Physiol, April 1, 1998; 274(4): L542 - L551. [Abstract] [Full Text] [PDF]

				T. N. George, O. L. Miakotina, K. L. Goss, and J. M. Snyder Mechanism of all trans-retinoic acid and glucocorticoid regulation of surfactant protein mRNA Am J Physiol Lung Cell Mol Physiol, April 1, 1998; 274(4): L560 - L566. [Abstract] [Full Text] [PDF]

				A. R. Kumar and J. M. Snyder Differential regulation of SP-A1 and SP-A2 genes by cAMP, glucocorticoids, and insulin Am J Physiol Lung Cell Mol Physiol, February 1, 1998; 274(2): L177 - L185. [Abstract] [Full Text] [PDF]